RAZADYNE Side Effects

6642912-4 | No Adverse Event
on Mar 04, 2010 Female patient from UNITED STATES , 81 years of age, was diagnosed with insomnia and was treated with Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event. Razadyne dosage: . During the same period patient was treated with RAMELTEON (View Ramelteon Review and Ramelteon Label ).

6641984-0 | No Adverse Event
Patient was taking Razadyne (View Usage). Patient had the following side effects: no adverse event on Mar 04, 2010 from UNITED STATES Additional patient health information: Female patient , 73 years of age, . Razadyne dosage: . During the same period patient was treated with ROZEREM (View Rozerem Review and Rozerem Label ).

6312894-3 | Myocardial Infarction
Adverse event was reported on Aug 14, 2009 by a Female patient taking Razadyne (View Usage) (Dosage: ) was diagnosed with dementia alzheimer's type, blood pressure (What is blood pressure?) and. Location: UNITED STATES , weighting 140.0 lb, After Razadyne was administered, patient had the following side effects: myocardial infarction. During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ).

6142282-4 | Headache
on Apr 02, 2009 Female patient from UNITED STATES , 88 years of age, weighting 120.0 lb, was diagnosed with dementia (What is dementia?) and was treated with Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?). Razadyne dosage: 4 Mg Bid Po. During the same period patient was treated with LEVOTHROID (View Levothroid Review and Levothroid Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), FOSAMAX (View Fosamax Review and Fosamax Label ).


5968704-7 | Abnormal Dreams, Feeling Abnormal, Headache, Middle Insomnia, Underdose
on Nov 24, 2008 Male patient from UNITED STATES , 82 years of age, weighting 155.0 lb, was diagnosed with dementia (What is dementia?), hypertension and was treated with Razadyne (View Usage). Patient had the following side effects: abnormal dreams, feeling abnormal, headache (What is headache?), middle insomnia, underdose. Razadyne dosage: . During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ), TRIAMTERENE (View Triamterene Review and Triamterene Label ).

5926944-7 | Asthenia, Hypotension, Somnolence
Patient was taking Razadyne (View Usage). After Razadyne was administered, patient had the following side effects: asthenia, hypotension, somnolence on Oct 21, 2008 from UNITED STATES Additional patient health information: Female patient , 80 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and. Razadyne dosage: 8 Mg Daily Po. Patient was hospitalized.

5876164-X | Cerebral Haemorrhage, Hallucination, Auditory
Adverse event was reported on Sep 03, 2008 by a Female patient taking Razadyne (View Usage) (Dosage: ) . Location: UNITED STATES , 82 years of age, Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, hallucination, auditory. Patient was hospitalized.

5832487-1 | Abnormal Dreams, Feeling Abnormal, Headache, Middle Insomnia, Underdose
on Jul 25, 2008 Male patient from UNITED STATES , 82 years of age, weighting 155.0 lb, was diagnosed with dementia (What is dementia?), hypertension and was treated with Razadyne (View Usage). Patient had the following side effects: abnormal dreams, feeling abnormal, headache (What is headache?), middle insomnia, underdose. Razadyne dosage: . During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ), TRIAMTERENE (View Triamterene Review and Triamterene Label ).

5802149-5 | Dizziness, Hypotension
on Jun 29, 2008 Female patient from UNITED STATES , weighting 101.0 lb, was diagnosed with dementia alzheimer's type, hypertension, blood cholesterol increased and was treated with Razadyne (View Usage). After Razadyne was administered, patient had the following side effects: dizziness (What is dizziness?), hypotension. Razadyne dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), COREG (View Coreg Review and Coreg Label ), PREVACID (View Prevacid Review and Prevacid Label ), AVAPRO (View Avapro Review and Avapro Label ), LASIX (View Lasix Review and Lasix Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5789139-6 | Abnormal Dreams
Patient was taking Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal dreams on Jun 16, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 125.0 lb, was diagnosed with amnesia and. Razadyne dosage: .

5752240-7 | Catatonia
Adverse event was reported on May 22, 2008 by a Female patient taking Razadyne (View Usage) (Dosage: ) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , 84 years of age, Patient had the following side effects: catatonia. During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ), ARICEPT (View Aricept Review and Aricept Label ), MACRODANTIN (View Macrodantin Review and Macrodantin Label ).

5746060-7 | Akathisia, Confusional State, Dementia, Dizziness, Dyskinesia, Dystonia, Encephalitis, Encephalopathy
on May 15, 2008 Female patient from UNITED STATES , weighting 260.0 lb, was diagnosed with sleep disorder (What is sleep disorder?) and was treated with Razadyne (View Usage). After Razadyne was administered, patient had the following side effects: akathisia, confusional state, dementia (What is dementia?), dizziness (What is dizziness?), dyskinesia, dystonia (What is dystonia?), encephalitis (What is encephalitis?), encephalopathy. Razadyne dosage: And 16 Mg Every Other Day.

5640117-7 | Anxiety, Cardiac Failure Congestive
on Feb 26, 2008 Male patient from UNITED STATES , 37 years of age, weighting 333.0 lb, was diagnosed with schizophrenia and was treated with Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), cardiac failure congestive. Razadyne dosage: 12mg Twice A Day Po. During the same period patient was treated with CDP CHOLINE (1000mg Twice A Day Po) (View Cdp Choline Review and Cdp Choline Label ). Patient was hospitalized.

5600876-6 | Communication Disorder, Constipation, Fall, Haemorrhoids, Muscle Twitching, Rectal Haemorrhage, Sleep Disorder, Ulcer
Patient was taking Razadyne (View Usage). Patient had the following side effects: communication disorder, constipation (What is constipation?), fall (What is fall?), haemorrhoids, muscle twitching, rectal haemorrhage, sleep disorder (What is sleep disorder?), ulcer (What is ulcer?) on Jan 17, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 238.0 lb, was diagnosed with dementia (What is dementia?), parkinson's disease (What is parkinson's disease?), blood pressure (What is blood pressure?), bladder disorder, blood potassium, hyperchlorhydria, blood cholesterol, hypersensitivity and. Razadyne dosage: . During the same period patient was treated with CARBOLEVO (View Carbolevo Review and Carbolevo Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), DETROL (View Detrol Review and Detrol Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PROTONIX (View Protonix Review and Protonix Label ), PROVACHOL (View Provachol Review and Provachol Label ), CLARINEX (View Clarinex Review and Clarinex Label ). Patient was hospitalized.

5553349-3 | Confusional State, Dizziness, Headache, Hot Flush, Impaired Work Ability, Malaise, Motor Dysfunction
Adverse event was reported on Dec 10, 2007 by a Female patient taking Razadyne (View Usage) (Dosage: 30 Tablets 8 Mg Once A Day Po And 1 Pill Every Other Day) was diagnosed with sleep disorder (What is sleep disorder?) and. Location: UNITED STATES , weighting 260.0 lb, After Razadyne was administered, patient had the following side effects: confusional state, dizziness (What is dizziness?), headache (What is headache?), hot flush, impaired work ability, malaise, motor dysfunction. Patient was hospitalized.

5488036-3 | Head Injury
on Oct 15, 2007 Male patient from UNITED STATES , weighting 184.0 lb, was diagnosed with dementia (What is dementia?), blood cholesterol, cerebrovascular accident, neuropathy peripheral, gastrooesophageal reflux disease and was treated with Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: head injury. Razadyne dosage: . During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PLAVIX (View Plavix Review and Plavix Label ), CARBATROL (View Carbatrol Review and Carbatrol Label ), ACIPHEX (View Aciphex Review and Aciphex Label ).

5450281-0 | Face Injury
on Sep 04, 2007 Male patient from UNITED STATES , weighting 184.0 lb, was diagnosed with dementia (What is dementia?), blood cholesterol, cerebrovascular accident, neuropathy peripheral, gastrooesophageal reflux disease and was treated with Razadyne (View Usage). Patient had the following side effects: face injury. Razadyne dosage: . During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PLAVIX (View Plavix Review and Plavix Label ), CARBATROL (View Carbatrol Review and Carbatrol Label ), ACIPHEX (View Aciphex Review and Aciphex Label ).

5346022-8 | Blood Pressure Increased
Patient was taking Razadyne (View Usage). After Razadyne was administered, patient had the following side effects: blood pressure increased on Nov 14, 2006 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 230.0 lb, was diagnosed with memory impairment and. Razadyne dosage: 4 Mg, 2 In 1 Day, Oral. During the same period patient was treated with ZALATAN (LATANOPROST) DROPS (View Zalatan (latanoprost) Drops Review and Zalatan (latanoprost) Drops Label ), SYNTHROID (LEVOTHYROXINE SODIUM) TABLET (View Synthroid (levothyroxine Sodium) Tablet Review and Synthroid (levothyroxine Sodium) Tablet Label ), ZETIA (CHOLESTEROL AND TRIGLYCERIDE REDUCERS) TABLET (View Zetia (cholesterol- And Triglyceride Reducers) Tablet Review and Zetia (cholesterol- And Triglyceride Reducers) Tablet Label ).

5346002-2 | Heart Rate Decreased
Adverse event was reported on Oct 30, 2006 by a Male patient taking Razadyne (View Usage) (Dosage: 8 Mg, 1 In 1 Day, Oral) was diagnosed with dementia (What is dementia?) and. Location: UNITED STATES , 77 years of age, weighting 180.0 lb, Patient experienced the following unwanted or unexpected effects: heart rate decreased. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), QUINAPRIL HCL (View Quinapril Hcl Review and Quinapril Hcl Label ). Patient was hospitalized.

5345933-7 | Feeling Abnormal, Headache, Regressive Behaviour, Sleep Disorder, Weight Decreased
on Oct 25, 2006 Female patient from UNITED STATES , 88 years of age, weighting 145.0 lb, was diagnosed with dementia alzheimer's type and was treated with Razadyne (View Usage). Patient had the following side effects: feeling abnormal, headache (What is headache?), regressive behaviour, sleep disorder (What is sleep disorder?), weight decreased. Razadyne dosage: 8 Mg, 2 In 1 Day, Oral. During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ), SPIROLACTONE (SPIRONOLACTONE) (View Spirolactone (spironolactone) Review and Spirolactone (spironolactone) Label ), L THYROXINE (LEVOTHYROXINE SODIUM) (View L-thyroxine (levothyroxine Sodium) Review and L-thyroxine (levothyroxine Sodium) Label ), PREMARIN (View Premarin Review and Premarin Label ).

5345882-4 | Myocardial Infarction
on Nov 28, 2006 Female patient from UNITED STATES , 88 years of age, weighting 120.0 lb, was diagnosed with dementia alzheimer's type and was treated with Razadyne (View Usage). After Razadyne was administered, patient had the following side effects: myocardial infarction. Razadyne dosage: , 1 In 1 Day, Oral. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), NAMENDA (View Namenda Review and Namenda Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), BABY ASPIRIN (ACETYSALICYLIC ACID) TABLET (View Baby Aspirin (acetysalicylic Acid) Tablet Review and Baby Aspirin (acetysalicylic Acid) Tablet Label ).

5345874-5 | Aggression, Paranoia
Patient was taking Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, paranoia on Jan 02, 2007 from UNITED STATES Additional patient health information: Male patient , 75 years of age, weighting 190.0 lb, was diagnosed with dementia alzheimer's type and. Razadyne dosage: 4 Mg, 2 In 1 Day, Oral. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

5345869-1 | Cerebrovascular Accident
Adverse event was reported on Mar 20, 2006 by a Female patient taking Razadyne (View Usage) (Dosage: 12 Mg, 1 In 1 Day) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , 80 years of age, Patient had the following side effects: cerebrovascular accident. During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ). Patient was hospitalized and became disabled.

5272618-8 | Hypotension, Sinus Bradycardia
on Mar 20, 2007 Female patient from UNITED STATES , 80 years of age, weighting 165.0 lb, was diagnosed with dementia (What is dementia?) and was treated with Razadyne (View Usage). After Razadyne was administered, patient had the following side effects: hypotension, sinus bradycardia. Razadyne dosage: Daily Po. Patient was hospitalized.

5260822-4 | Headache, Incontinence, Insomnia
on Mar 01, 2007 Female patient from UNITED STATES , weighting 253.0 lb, was diagnosed with insomnia, migraine (What is migraine?), weight decreased, blood cholesterol increased, thyroid disorder, contraception, multiple allergies and was treated with Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), incontinence, insomnia. Razadyne dosage: . During the same period patient was treated with ROZEREM (View Rozerem Review and Rozerem Label ), TOPAMAX (View Topamax Review and Topamax Label ), NYASPAN (View Nyaspan Review and Nyaspan Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), YASMIN (View Yasmin Review and Yasmin Label ), SINGULAIR (View Singulair Review and Singulair Label ).

5243663-3 | Ankle Fracture, Insomnia
Patient was taking Razadyne (View Usage). Patient had the following side effects: ankle fracture, insomnia on Feb 15, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 122.0 lb, was diagnosed with memory impairment, sinus disorder, sleep disorder (What is sleep disorder?) and. Razadyne dosage: . During the same period patient was treated with RAZADYNE ER (View Razadyne Er Review and Razadyne Er Label ), PREDNISONE 50MG TAB (View Prednisone 50mg Tab Review and Prednisone 50mg Tab Label ), AMBIEN (View Ambien Review and Ambien Label ). Patient was hospitalized.

5239410-1 | Headache, Incontinence, Insomnia
Adverse event was reported on Feb 06, 2007 by a Female patient taking Razadyne (View Usage) (Dosage: ) was diagnosed with insomnia, weight decreased, blood cholesterol increased, thyroid disorder, contraception and. Location: UNITED STATES , weighting 253.0 lb, After Razadyne was administered, patient had the following side effects: headache (What is headache?), incontinence, insomnia. During the same period patient was treated with ROZEREM (View Rozerem Review and Rozerem Label ), TOPAMAX (View Topamax Review and Topamax Label ), NYASPAN (View Nyaspan Review and Nyaspan Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), YASMIN (View Yasmin Review and Yasmin Label ).

5232305-9 | Ankle Fracture, Condition Aggravated, Insomnia
on Feb 01, 2007 Female patient from UNITED STATES , weighting 122.0 lb, was diagnosed with memory impairment, sinus disorder, sleep disorder (What is sleep disorder?) and was treated with Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: ankle fracture, condition aggravated, insomnia. Razadyne dosage: . During the same period patient was treated with RAZADYNE ER (View Razadyne Er Review and Razadyne Er Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), AMBIEN (View Ambien Review and Ambien Label ). Patient was hospitalized.

5199683-0 | Cerebral Haemorrhage, Decubitus Ulcer, Osteomyelitis
on Dec 27, 2006 Male patient from UNITED STATES , weighting 180.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Razadyne (View Usage). Patient had the following side effects: cerebral haemorrhage, decubitus ulcer, osteomyelitis. Razadyne dosage: . During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

5155190-2 | Cough, Multiple Myeloma, Pleural Fibrosis, Pneumothorax, Pulmonary Mass
Patient was taking Razadyne (View Usage). After Razadyne was administered, patient had the following side effects: cough, multiple myeloma (What is multiple myeloma?), pleural fibrosis, pneumothorax, pulmonary mass on Nov 14, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 105.0 lb, was diagnosed with dementia alzheimer's type, hypertension, osteoporosis (What is osteoporosis?), osteoarthritis (What is osteoarthritis?) and. Razadyne dosage: . During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), EVISTA (View Evista Review and Evista Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), RELAFEN (View Relafen Review and Relafen Label ).

5146781-3 | Cough, Pulmonary Mass
Adverse event was reported on Nov 02, 2006 by a Female patient taking Razadyne (View Usage) (Dosage: ) was diagnosed with dementia alzheimer's type, hypertension, osteoporosis (What is osteoporosis?), osteoarthritis (What is osteoarthritis?) and. Location: UNITED STATES , weighting 105.0 lb, Patient experienced the following unwanted or unexpected effects: cough, pulmonary mass. During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), EVISTA (View Evista Review and Evista Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), RELAFEN (View Relafen Review and Relafen Label ).

5145939-7 | Cough, Pulmonary Mass
on Oct 30, 2006 Female patient from UNITED STATES , weighting 105.0 lb, was diagnosed with dementia alzheimer's type, blood pressure abnormal, coagulopathy and was treated with Razadyne (View Usage). Patient had the following side effects: cough, pulmonary mass. Razadyne dosage: . During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), EVISTA (View Evista Review and Evista Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NABUMETONE (View Nabumetone Review and Nabumetone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5145117-1 | Cerebral Haemorrhage, Decubitus Ulcer, Osteomyelitis
on Oct 31, 2006 Male patient from UNITED STATES , weighting 180.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Razadyne (View Usage). After Razadyne was administered, patient had the following side effects: cerebral haemorrhage, decubitus ulcer, osteomyelitis. Razadyne dosage: . During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

5130676-5 | Cough, Pulmonary Mass
Patient was taking Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: cough, pulmonary mass on Oct 10, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 105.0 lb, was diagnosed with dementia alzheimer's type, blood pressure abnormal, coagulopathy and. Razadyne dosage: . During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), EVISTA (View Evista Review and Evista Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NABUMETONE (View Nabumetone Review and Nabumetone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5101527-X | Renal Failure
Adverse event was reported on Sep 01, 2006 by a Male patient taking Razadyne (View Usage) (Dosage: ) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , weighting 180.0 lb, Patient had the following side effects: renal failure. During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ).

5072447-4 | Renal Failure
on Jul 27, 2006 Male patient from UNITED STATES , weighting 180.0 lb, was diagnosed with dementia alzheimer's type and was treated with Razadyne (View Usage). After Razadyne was administered, patient had the following side effects: renal failure. Razadyne dosage: . During the same period patient was treated with NAMENDA (View Namenda Review and Namenda Label ).

5026032-0 | Myocardial Infarction
on Jan 24, 2006 Female patient from UNITED STATES , 88 years of age, was diagnosed with dementia alzheimer's type and was treated with Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Razadyne dosage: Oral.

5024639-8 | Somnolence
Patient was taking Razadyne (View Usage). Patient had the following side effects: somnolence on May 31, 2005 from UNITED STATES Additional patient health information: Female patient , 83 years of age, was diagnosed with dementia alzheimer's type and. Razadyne dosage: Oral.

5024638-6 | Weight Decreased
Adverse event was reported on Aug 05, 2005 by a Male patient taking Razadyne (View Usage) (Dosage: 8 Mg, 2 In 1 Day, Oral) was diagnosed with dementia (What is dementia?) and. Location: UNITED STATES , 90 years of age, weighting 165.0 lb, After Razadyne was administered, patient had the following side effects: weight decreased.

5024637-4 | Amnesia, Fall, Headache, Hypertension, Pollakiuria
on Jun 22, 2005 Female patient from UNITED STATES , 81 years of age, was diagnosed with dementia alzheimer's type and was treated with Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, fall (What is fall?), headache (What is headache?), hypertension, pollakiuria. Razadyne dosage: See Image. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), NAMENDA (MEMATINE) TABLETS (View Namenda (mematine) Tablets Review and Namenda (mematine) Tablets Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CENTRUM SILVER (CENTRUM SILVER) (View Centrum Silver (centrum Silver) Review and Centrum Silver (centrum Silver) Label ), CITRACAL (CALCIUM CITRATE) (View Citracal (calcium Citrate) Review and Citracal (calcium Citrate) Label ).

5024635-0 | Weight Decreased
on Jun 24, 2005 Male patient from UNITED STATES , 72 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with Razadyne (View Usage). Patient had the following side effects: weight decreased. Razadyne dosage: 8 Mg, 2 In 1 Day, Oral. During the same period patient was treated with SYNTHROID (LEVOTHYROXINE SODIUM) TABLETS (View Synthroid (levothyroxine Sodium) Tablets Review and Synthroid (levothyroxine Sodium) Tablets Label ).

5024616-7 | Convulsion
Patient was taking Razadyne (View Usage). After Razadyne was administered, patient had the following side effects: convulsion on Oct 25, 2005 from UNITED STATES Additional patient health information: Male patient , 75 years of age, was diagnosed with dementia (What is dementia?) and. Razadyne dosage: 8 Mg, 2 In 1 Day, Oral. During the same period patient was treated with REMINYL (GALANTAMINE HBR) TABLETS (4 Mg, 2 In 1 Day, Oral) (View Reminyl (galantamine Hbr) Tablets Review and Reminyl (galantamine Hbr) Tablets Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ISOSORBIDE (ISOSORBIDE) (View Isosorbide (isosorbide) Review and Isosorbide (isosorbide) Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LUPRON (View Lupron Review and Lupron Label ).

5004149-4 | Anorexia, Asthenia, Atelectasis, Blood Creatinine Increased, Blood Glucose Increased, Blood Urea Increased, Brain Natriuretic Peptide Increased, Ejection Fraction Decreased, Pleural Effusion
Adverse event was reported on May 05, 2006 by a Male patient taking Razadyne (View Usage) (Dosage: ) was diagnosed with cardiac failure and. Location: UNITED STATES , weighting 143.0 lb, Patient experienced the following unwanted or unexpected effects: anorexia, asthenia, atelectasis, blood creatinine increased, blood glucose increased, blood urea increased, brain natriuretic peptide increased, ejection fraction decreased, pleural effusion. During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), FLUVASTATIN SODIUM (View Fluvastatin Sodium Review and Fluvastatin Sodium Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ). Patient was hospitalized.

4981122-3 | Renal Failure
on Apr 14, 2006 Female patient from UNITED STATES , 83 years of age, was treated with Razadyne (View Usage). Patient had the following side effects: renal failure. Razadyne dosage: .

4977551-4 | Intraocular Pressure Increased, Prostatic Specific Antigen Increased
on Apr 11, 2006 Male patient from UNITED STATES , 84 years of age, weighting 160.0 lb, was treated with Razadyne (View Usage). After Razadyne was administered, patient had the following side effects: intraocular pressure increased, prostatic specific antigen increased. Razadyne dosage: .

4960806-7 | Incorrect Dose Administered
Patient was taking Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: incorrect dose administered on Mar 31, 2006 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 258.0 lb, . Razadyne dosage: . During the same period patient was treated with ROZEREM (View Rozerem Review and Rozerem Label ).

4943486-6 | Gastrointestinal Obstruction, Sepsis
Adverse event was reported on Mar 06, 2006 by a Female patient taking Razadyne (View Usage) (Dosage: ) was diagnosed with tremor and. Location: UNITED STATES , weighting 110.0 lb, Patient had the following side effects: gastrointestinal obstruction, sepsis (What is sepsis?). During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ). Patient was hospitalized.

4937234-3 | Cardiac Failure Congestive, Chronic Obstructive Pulmonary Disease
on Mar 01, 2006 Female patient from UNITED STATES , weighting 125.0 lb, was treated with Razadyne (View Usage). After Razadyne was administered, patient had the following side effects: cardiac failure congestive, chronic obstructive pulmonary disease. Razadyne dosage: . During the same period patient was treated with ULTRAM (View Ultram Review and Ultram Label ).

4909380-1 | Cardiac Failure Congestive, Chronic Obstructive Pulmonary Disease
on Feb 08, 2006 Female patient from UNITED STATES , 79 years of age, weighting 125.0 lb, was treated with Razadyne (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, chronic obstructive pulmonary disease. Razadyne dosage: . During the same period patient was treated with ULTRAM (View Ultram Review and Ultram Label ).

4903375-X | Dementia, Speech Disorder, Tremor
Patient was taking Razadyne (View Usage). Patient had the following side effects: dementia (What is dementia?), speech disorder, tremor on Feb 06, 2006 from UNITED STATES Additional patient health information: Female patient , 81 years of age, was diagnosed with dementia alzheimer's type and. Razadyne dosage: 8 Mg Po Daily. Patient was hospitalized.